According to research report the in vitro toxicology testing market size is expected to reach USD 18.6 billion by 2027 from an estimated USD 11.2 billion in 2022, at a CAGR of 10.8%. The major factors driving the growth of this market are the technological advancements, opposition to animal testing, and increasing RD expenditure to detect toxicity at an early stage during drug development are the primary growth drivers for this market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065
Due to covid-19 outbreak it is expected to propel the in vitro
toxicology research field in the coming years. On the other hand,
estimation of the major share of diagnostic assays and molecular testing
of Covid-19, along with personalized medicine will grow at a stable
pace in the coming years. There is a huge increase of manufacturers that
have taken key steps to increase patient access for diagnostic testing,
vaccine and drug development in laboratories, hospitals, and other
testing sites across the globe to guide patient care and protect public
health.
During the forecast period in the
toxicity endpoints and tests market, the organ toxicity segment is
expected to grow at the highest in the market.
During
the forecast period the organ toxicity segment is expected to grow at
the highest in the market. Primary factors responsible for the growth in
this segment are the increasing focus on drug safety and
consumer-product safety.
By product and service, the
consumables segment is expected to account for the largest share of the
in vitro toxicology testing market
The consumables
segment is estimated to account for the largest in vitro toxicology
testing market share in 2021. Due to the increasing demand for
high-quality reagents and the repeated use of media and reagents in
vitro toxicology studies, the segment is attributed to grow.
Based
on the technologies used in the in vitro toxicology testing, the cell
culture technologies segment is expected to account for the largest
share of the in vitro toxicology testing market
In
2021, the cell culture technologies segment is estimated to account for
the largest market share. The cell culture technologies technique is the
most preferred technique for toxicity testing, being capable of
mimicking in vivo conditions and this the main reason that it will drive
the largest market share.
By regional in vitro
toxicology testing trend the Asia Pacific is estimated to be the
fastest-growing during the forecast period
The APAC
market is projected to register the highest growth during the forecast
period. Factors such as, opposition to animal testing resulting in the
use of alternate methods, emergence of CROs for outsourcing
toxicology-related research projects, growing consumer awareness of
product safety, and increasing pharmaceutical drug pipeline, are some of
the key factors driving the growth of the in vitro toxicology testing
market in the APAC.
Request For Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=209577065
The prominent players in the in vitro toxicology testing market
include Thermo fisher Scientific, Inc. (US), Laboratory Corporation of
America Holdings (US), Bio-Rad Laboratories, Inc. (US), General Electric
Company (US), Eurofins Scientific (Luxembourg), Merck KGaA (Germany),
Charles River Laboratories International, Inc. (US), Catalent, Inc.
(US), Evotec (UK), SGS S.A. (Switzerland), QIAGEN (Germany), Promega
Corporation (US), Gentronix Limited (UK), BioIVT (US), and MB Research
Laboratories (US).
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
Releated Reports: https://www.marketsandmarkets.com/Market-Reports/in-vitro-diagnostics-quality-controls-market-198032582.html
